期刊文献+

甘露醇开放血脑屏障在大鼠脑胶质瘤动脉介入化疗应用中的价值 被引量:4

Experimental Study of the Value of Openning Blood Brain Barriar with Mannitol to Intraarterial Chemotherapy of Glioma
下载PDF
导出
摘要 目的:探讨甘露醇在动脉介入治疗脑肿瘤中的应用价值。材料和方法:SD雄性大鼠100只,在鼠脑尾状核头部,种植C 6大鼠胶质瘤细胞。 MRI检查使用超导磁共振成像系统。化疗药为 VM-26和MTX。结果:VM-26动脉化疗组是否使用甘露醇疗效无显著性差异。MTX动脉化疗组是否使用甘露醇疗效有显著差异。VM-26和MTX的甘露醇动脉化疗组之间,疗效无显著差异。VM-26动脉化疗组疗效明显优于静脉化疗组。结论:甘露醇对脂溶性化疗药物的疗效作用意义不大。在水溶性化疗药物化疗前,有必要应用开放血脑屏障的技术。 Purposes: To evaluate the applicated value of mannitol opening blood brain barrier to the intraarterial chemotherapy of glioma. Materials and methods: Under stereotactic, c6 rat glioma cell were implanted into the right caudate nucleus of male SD rat. Super conduct MRI system, Gd.-DTPA as MRI contract, were used to measure rat brain tumor volume. Two chemotherapy drugs, VM26 and MTX, were used in intraarterial and venous chemotherapy. Results: There was no significant statistical difference between VM26 with mannltol and VM26 without mannitol. There was significant statistical difference between MTX with mannitol and MTX without manni tol. There was no statistical difference between VM26 with or without mannitol and MTX with mannitol. Conclusion: There are no cer tain significance that mannitol affect the curative effect in treating brain tumor with lipophilic anti-brain tumor compounds. it's necessary to open blood brain barrier before water soluble compounds of anti-brain tumor are used.
出处 《中国医学影像学杂志》 CSCD 2000年第2期127-130,共4页 Chinese Journal of Medical Imaging
基金 国家自然科学基金!批准号36970231
关键词 血脑屏障 甘露醇 化疗 脑肿瘤 blood brain barrier mannitol intraarterial chemotherapy brain neoplasm rat
  • 相关文献

参考文献5

二级参考文献66

  • 1陈允硕,吴健民.肿瘤标志物临床检测的基本原则(建议稿)[J].中华检验医学杂志,2004,27(6):393-393. 被引量:35
  • 2De Angelis R, Sam M, C01eman MP, et al. Cancer survival in Eu- rope 1999-2007 by country and age: Results of EUROCARE -5 - a population - based study[ J]. Lancet Oncol,2014,15 ( 1 ) :23 - 34.
  • 3Ettinger DS, Bepler G, Bueno R, et al. Non - small cell lung cancer clinical practice guidelines in oncology [ J ]. Natl Compr Cane Netw,2006,4 ( 6 ) :548 - 582.
  • 4Katsunari Matsuoka, Shiniehi Sumitomo, Nakashima M, et al. Prog- nostic value of eareinoembryonie antigen and CYFRA21 - 1 in pa- iients with pathological stage I non - small cell lung cancer[ J]. Eur J Cardiothorac Surg,2007,32(3 ) :435 -439.
  • 5Lazarev SM, Massard ZH, Reshetov AV, et al. Role of biological tumor markers CEA, CYFRA21, NSE,TUM2 -PK in diagnosis and treatment of lung cancer[ J]. Vestnik khirurgii imeni I I Greko- va,2010,169 ( 1 ) : 39 - 43.
  • 6Hennessy BT, Hortobagyi GN ~ Rouzier R, et al. Outcome after path- ologic complete eradication of cytologically proven breast cancer ax- illary node metastases following primary chemotherapy [ J ]. J Clin Oneol,2005,23:9304 - 9311.
  • 7Kozu Y, Maniwa T,Takahashi S, et al. Pr, :., ignifieance of l~t~toperative Serum carcinoembryonic an< in patients with completely resected pathological - stage i ~, .mall cell lung cancer [J]. J Cardiothorac Surg,2013,8(1 ) :108.
  • 8Cedres S,Nunez I, Longo M,et al. Serum tumor ~rkcrs CEA, CY- FRA21 - 1, and CA125 are associated with worse prognosis in ad- vanced non - small - cell lung cancer ( NSCLC ) [ J ]. Clin Lung Cancer,2011,12 (3) : 172 - 179.
  • 9Nagashima T, Sakae Y, Mun M, et al. A clinicopathological study of resected small - sized squamos cell carcinomas of the pcriph eral lung: Prognostic significance of serum carcinoembryonic antigen levels[J]. Ann Thorax Cardiovasc Surg,2013,19(5) :351 -357.
  • 10Bodenmuller H, Ofenloch - Hahnle B. Lung cancer - associated keratin 19 fragments:Development and biochemical characterisati- on of the new serum assay enzymun - test CYFRA21 - 1 [ J]. Int J Biol Markers, 1994,9 ( 2 ) : 75 - 81.

共引文献93

同被引文献55

  • 1王瑞林,宋文广,付占昭,张志勇,吴瑜,钟延丰,王胜兰.脑转移癌血脑屏障变化的免疫组化及超微结构研究[J].中国肿瘤临床,2004,31(17):977-979. 被引量:23
  • 2陈系古,黄冰,李智,黄文革.肿瘤颅内外转移机理的实验性探讨[J].中国实验动物学报,1996,4(2):123-127. 被引量:1
  • 3王明盛,杨正明,陈坚.卡铂、威猛、甲氨蝶呤、尼莫地平联用对脑胶质瘤的抑制作用[J].山东医药,2005,45(10):22-23. 被引量:5
  • 4顾科,张军宁.成人Ⅱ级以上脑胶质瘤术后同步放化疗疗效分析[J].肿瘤防治研究,2007,34(8):626-628. 被引量:13
  • 5Rapoport S I,Robinson P J,Size.selectivity of blood-brain barrier permeability at various times after osmotic opening[J].Am J Physiol,1999,219:217-224.
  • 6江涛,马文斌,杨学军.胶质瘤治疗技术与进展[M].北京:人民卫生出版社,2011:288.
  • 7Ramalho-Carvalho J, Pires M, Lisboa S, et al. Altered expression of MGMT in high-grade gliomas results from the combined effect of epigenetic and genetic aberrations [ J ]. PLoS One, 2013,8 (3) :1- 11.
  • 8Knizhnik A, Roos WP, Nikolova T, et al. Survival and death strategies in glioma cells: autophagy, senescence and apoptosis triggered by a single type of temozolomide-induced DNA damage [J]. PLoS One, 2013,8(1):1-12.
  • 9陈金炳.MGMT基因在胶质细胞瘤治疗中的意义[J].贵阳医药,2005,8,29(8):765-766.
  • 10Ueki K, Nishikawa R, Nakazato Y, et al. Correlation of histology and molecular genetic analysis of lp, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors [ J]. Clin Cancer Res, 2002,8 ( 1 ) : 196-201.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部